CMEGuidelines for Hepatitis C in Chronic Kidney Disease IssuedThe Kidney Diseases Improving Global Outcomes foundation addresses the prevention, management, and treatment of hepatitis C in chronic kidney disease and in those undergoing hemodialysis.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the National Kidney Foundation. These materials and the related activity are not sanctioned by the National Kidney Foundation or the commercial supporter of the conference and do not constitute an official part of that conference.
